What to Know About Surgery with Von Willebrand Disease

Published: Apr 25, 2024

Surgery in patients with von Willebrand Disease (VWD) requires special considerations. This article outlines the key strategies for managing VWD during major surgical procedures.
Contents

Preparing for Surgery with VWD

For individuals with VWD, preparation for surgery involves raising VWF levels to ensure proper clotting. This is done by administering VWF concentrates intravenously before the procedure. The goal is to achieve a VWF activity level of about 100 IU/dL, checked in the recovery room to avoid delays.

Managing VWF Levels During Surgery

VWF levels are maintained above 50 IU/dL throughout the surgery using repeated infusions. The frequency of infusions, typically every 8 to 12 hours, is determined based on the patient's response and clinical picture. Continuous monitoring ensures any rapid clearance or recovery issues are promptly addressed.
Von Willebrand Disease (VWD) is a genetic blood disorder that affects the body's ability to clot properly, posing challenges during surgical procedures.

Addressing Potential Complications

During surgery, complications like thrombosis may arise if factor VIII levels become excessively elevated. Careful monitoring helps prevent such risks by adjusting dosages. In some cases, continuous infusion of VWF may be necessary to manage inhibitors effectively.

Frequently Asked Questions

Levels are maintained above 50 IU/dL with repeated infusions.

The target level is about 100 IU/dL.

It helps manage rapid clearance and prevent complications.

Wrapping Up

Effective management of VWF levels is essential for safe surgical outcomes in VWD patients.
Planning surgery with VWD? Talk to Doctronic about your options.

Related Articles

References

  1. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14:171.
  2. Peyvandi F, Mamaev A, Wang JD, et al. Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. J Thromb Haemost 2019; 17:52.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely